Clinical Trial Update: Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Rexlemestrocel-L in combination with hyaluronic acid for moderate to severe chronic low back pain due to degenerative disc disease is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)
• Rexlemestrocel-L (allogeneic mesenchymal precursor cells)

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Degenerative Disc Disease | Phase 3 | Status: RECRUITING